Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)
CUSIP: 603380205
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 45,675,986
- Total 13F shares
- 2,085,897
- Share change
- -32,244
- Total reported value
- $4,630,050
- Price per share
- $2.22
- Number of holders
- 21
- Value change
- -$81,975
- Number of buys
- 5
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 603380205?
CUSIP 603380205 identifies NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 603380205:
Top shareholders of NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,275,000
|
$4,794,000 | — | 27 Jun 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
3%
|
1,351,275
|
$3,607,904 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.55%
|
252,060
|
$673,001 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.34%
|
157,200
|
$419,724 | — | 30 Sep 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.23%
|
107,256
|
$286,374 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.16%
|
72,669
|
$194,026 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
56,456
|
$150,774 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
23,049
|
$61,540 | — | 30 Sep 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
20,224
|
$53,998 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
17,239
|
$46,028 | — | 30 Sep 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.04%
|
17,416
|
$46,000 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
16,519
|
$44,106 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
10,747
|
$28,694 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
10,552
|
$28,174 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,938
|
$5,174 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,908
|
$5,095 | — | 30 Sep 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0%
|
1,175
|
$3,137 | — | 30 Sep 2024 | |
| TFC Financial Management, Inc. |
13F
|
Company |
0%
|
186
|
$497 | — | 30 Sep 2024 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
100
|
$267 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
57
|
$152 | — | 30 Sep 2024 | |
| Anchor Investment Management, LLC |
13F
|
Company |
0%
|
12
|
$32 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
3/4/5
|
Company · 10%+ Owner |
0%
|
3
|
$8 | — | 30 Sep 2024 | |
| Jeryl L. Hilleman |
3/4/5
|
Director |
—
class O/S missing
|
12,500
|
— | — | 27 Sep 2023 | |
| William F. Doyle |
3/4/5
|
Director |
—
class O/S missing
|
2,500
|
— | — | 10 Jun 2022 |
Institutional Holders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) as of Q4 2024
As of 31 Dec 2024,
Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,085,897 shares.
The largest 10 holders included
FEDERATED HERMES, INC., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, CITADEL ADVISORS LLC, ACADIAN ASSET MANAGEMENT LLC, and STATE STREET CORP.
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
19
Q4 2024 holders
21
Holder diff
2
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.